Here's all you need to know about the human trial of Covaxin:No side-effect so far: A 30-year-old man took the first dose of COVID-19 vaccine candidate at Delhi's All India Institutes of Medical Sciences (AIIMS) last week as part of human trial. "No immediate side-effects have been observed so far," Dr Sanjay Rai, professor at the centre for community medicine at AIIMS said.Covaxin shows "encouraging" results in PGIMS RohtakThe first phase of human trial was completed in PGIMS Rohtak.
The hospital started trial on July 17 and around 50 volunteers enrolled for this exercise. "50 people across India were administered the vaccine and the results were encouraging," Dr Savita Verma, principal investigator of the vaccine trial team, told news.